All material subject to strictly enforced copyright laws. © 2022 Euromoney Institutional Investor PLC group
Corporate Bonds

Syngenta's €500m 12 year comes without NIP

Lab work

Syngenta, the company created in 2000 through the merger of the spun-off agribusinesses of Swiss pharmaceutical company Novartis and the UK's AstraZeneca, has priced a €500m 12.5 year bond.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree